SBA presses CMS on DIR fees

by NCPA | Sep 17, 2019

Following testimony by NCPA member and pharmacy owner Brian Hose, the Small Business Administration National Ombudsman sent an inquiry to CMS regarding CMS' engagement on pharmacy DIR fees and requesting a high-level review of the concerns raised during Hose's remarks. The SBA is looking at the effect DIR fees have on small business community pharmacies. Hose testified at the SBA's Regulatory Fairness Hearing on how pharmacy DIR fees affect his small business. CMS is required to respond within 30 days.